VELIER, M.; SIMONCINI, S.; ABELLAN, M.; FRANCOIS, P.; EAP, S.; LAGRANGE, A.; BERTRAND, B.; DAUMAS, A.; GRANEL, B.; DELORME, B.;
et al. Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro. J. Clin. Med. 2019, 8, 1979.
https://doi.org/10.3390/jcm8111979
AMA Style
VELIER M, SIMONCINI S, ABELLAN M, FRANCOIS P, EAP S, LAGRANGE A, BERTRAND B, DAUMAS A, GRANEL B, DELORME B,
et al. Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro. Journal of Clinical Medicine. 2019; 8(11):1979.
https://doi.org/10.3390/jcm8111979
Chicago/Turabian Style
VELIER, Mélanie, Stéphanie SIMONCINI, Maxime ABELLAN, Pauline FRANCOIS, Sandy EAP, Anaïs LAGRANGE, Baptiste BERTRAND, Aurélie DAUMAS, Brigitte GRANEL, Bruno DELORME,
and et al. 2019. "Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro" Journal of Clinical Medicine 8, no. 11: 1979.
https://doi.org/10.3390/jcm8111979
APA Style
VELIER, M., SIMONCINI, S., ABELLAN, M., FRANCOIS, P., EAP, S., LAGRANGE, A., BERTRAND, B., DAUMAS, A., GRANEL, B., DELORME, B., DIGNAT GEORGE, F., MAGALON, J., & SABATIER, F.
(2019). Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro. Journal of Clinical Medicine, 8(11), 1979.
https://doi.org/10.3390/jcm8111979
